Media Room Menu
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Jan 20, 2010"AFib Support Team" Offers Insights on Comprehensive Approach to Management of Serious Heart Condition
-
Dec 21, 2009Fluzone® High-Dose (Influenza Virus Vaccine) strengthens immune response in the 65+ population, an age group that suffers disproportionately from influenza and its complications
-
Dec 21, 2009-- Combination Strengthens sanofi-aventis' Strategy to Accelerate Growth Through Innovation, Geographic Expansion and External Growth
-
Dec 15, 2009Novel vaccine approach tested against one of the most common causes of hospital-acquired infection in Europe and North America
-
Dec 11, 2009- Atul Dhir, M.D., Ph.D. has been appointed new BiPar CEO to continue growing entrepreneurial and innovative culture -
-
Nov 11, 2009Final data confirm immunogenicity, safety profile
-
Nov 2, 2009The two-dose meningococcal quadrivalent conjugate vaccine was generally well-tolerated